CD45 Antikörper (FITC)
Kurzübersicht für CD45 Antikörper (FITC) (ABIN2480516)
Target
Alle CD45 (PTPRC) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
-
Immunogen
- Rat thymocyte membrane glycoproteins.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.1 mg/mL
-
-
-
: "Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy." in: Journal of the National Cancer Institute, Vol. 99, Issue 23, pp. 1768-81, (2007) (PubMed).
: "Distribution of OX2 antigen and OX2 receptor within retina." in: Investigative ophthalmology & visual science, Vol. 42, Issue 1, pp. 170-6, (2001) (PubMed).
-
: "Effect of tumor microenvironment modulation on the efficacy of oncolytic virus therapy." in: Journal of the National Cancer Institute, Vol. 99, Issue 23, pp. 1768-81, (2007) (PubMed).
-
- CD45 (PTPRC) (Protein tyrosine Phosphatase, Receptor Type, C (PTPRC))
-
Andere Bezeichnung
- CD45
-
Hintergrund
- Synonyms: LCA
-
Gen-ID
- 24699
-
UniProt
- P04157
-
Pathways
- T-Zell Rezeptor Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, BCR Signaling
Target
-